Evidence map›Paper›PMID 35190451›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2022

Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistant

Rania Kousovista, Christos Athanasiou, Konstantinos Liaskonis, Olga Ivopoulou, Vangelis D Karalis

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rania KousovistaDepartment of Mathematics and Applied Mathematics, University of Crete Heraklion Campus, Heraklion, Greece.ORCID 0000-0002-9883-0381
Christos AthanasiouPharmacy Department, 401 General Military Hospital of Athens, Athens, Greece.
Konstantinos LiaskonisDepartment of Medical Biopathology, 401 General Military Hospital of Athens, Athens, Greece.
Olga IvopoulouDepartment of Medical Biopathology, 401 General Military Hospital of Athens, Athens, Greece.
Vangelis D KaralisFaculty of Pharmacy, Laboratory of Biopharmaceutics - Pharmacokinetics, National and Kapodistrian University of Athens School of Health Sciences, Athens, Greece vkaralis@pharm.uoa.gr.
401 General Military Hospital of Athens · GRNational and Kapodistrian University of Athens · GRUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesColistin is currently considered an essential therapeutic option for the treatment of hospital-acquired infections caused by resistant isolates of

methodsSusceptibility data for

resultsThe results of the univariate model showed a statistically significant positive association between colistin use and the detection rate of colistin-resistant

conclusionsThis study quantifies the effect of colistin use on the development of resistant strains. These findings can assist antimicrobial stewardship teams to elaborate their plans and predict the effect of their interventions.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsColistinHospitalsHumansMicrobial Sensitivity TestsTime FactorsAnti-Bacterial AgentsColistindrug misusehealth services administrationhospitalpharmacy administrationpharmacy servicestatistics

Identifiers

PMID35190451
PMCPMC8899687
OpenAlexW4213022738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.